Evidence map›Paper›PMID 38862456›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2024

[High expression of ATP5A1 in gastric carcinoma is correlated with a poor prognosis and enhanced glucose metabolism in tumor cells].

J Yang, L Yin, T Duan, M Niu, Z He, X Chen, X Zhang, J Li, Z Geng, L Zuo

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. [SF3B3 overexpression promotes proliferation of gastric cancer cells and correlates with poor patient prognosis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  3. Anticancer Activity ofNutrients · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

J YangDepartment of Gastrointestinal surgery, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.
L YinCollege of clinical laboratory medicine, Bengbu Medical University, Bengbu 233030, China.
T DuanCollege of Clinical Medicine, Bengbu Medical University, Bengbu 233030, China.
M NiuCollege of clinical laboratory medicine, Bengbu Medical University, Bengbu 233030, China.
Z HeCollege of Clinical Medicine, Bengbu Medical University, Bengbu 233030, China.
X ChenCollege of Clinical Medicine, Bengbu Medical University, Bengbu 233030, China.
X ZhangCentral Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.
J LiClinical Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.
Z GengCentral Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.
L ZuoDepartment of Gastrointestinal surgery, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the expression level of ATP5A1 in gastric carcinoma and its influence on the prognosis of the patients and glucose metabolism in the tumor cells.

methodsWe retrospectively analyzed the data of 115 patients undergoing radical resection of gastric carcinoma in our hospital from February, 2013 to November, 2016. ATP5A1 expression in the surgical specimens were detected using immunohistochemistry, and the long-term prognosis of the patients with high (

resultsATP5A1 was significantly overexpressed in gastric carcinoma tissues in close correlation with blood CEA and CA19-9 levels, pathological grade, T stage and N stage (

conclusionHigh ATP5A1 expression in gastric cancer is associated a poor long-term prognosis of the patients, and its effect is mediated at least partly by promoting glucose metabolism of the cells through the JNK/JUN pathway.

Indexed as

GlucoseMice, NudeStomach NeoplasmsAnimalsCell Line, TumorFemaleHumansMaleMiceMitochondrial Proton-Translocating ATPasesPrognosisRetrospective StudiesSurvival RateATP5F1A protein, humanGlucoseMitochondrial Proton-Translocating ATPasesATP5A1gastric carcinomaglucose metabolismJNK/JUN pathwayprognosis

Identifiers

PMID38862456
PMCPMC11166711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.